What Researchers Did
Researchers interpreted six randomized clinical trials comparing hyperbaric oxygen therapy (HBO2) with normobaric oxygen for acute carbon monoxide poisoning.
What They Found
Of the six prospective clinical trials reviewed, four reported better clinical outcomes for patients receiving hyperbaric oxygen therapy (HBO2), while two showed no treatment effect. The most recent and best-designed trial supported HBO2 efficacy in severe acute carbon monoxide poisoning.
What This Means for Canadian Patients
Canadian patients experiencing severe acute carbon monoxide poisoning may benefit from hyperbaric oxygen therapy (HBO2) to potentially limit neurological complications. However, the optimal number of treatments and the maximum delay for HBO2 efficacy remain areas for further research.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
The study highlights unresolved issues regarding the optimal number of hyperbaric oxygen treatments and the maximum treatment delay for efficacy in carbon monoxide poisoning.